Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: Results from the Breathing Not Properly (BNP) multinational study

American Heart Journal

Volumn 147, Issue 6, 2004, Pages 1078-1084

  Maisel, Alan S ^a,j   Clopton, Paul ^a   Krishnaswamy, Padma ^a   Nowak, Richard M ^b   McCord, James ^b   Hollander, Judd E ^c   Duc, Philippe ^d   Omland, Torbjørn ^e   Storrow, Alan B ^f   Abraham, William T ^g   Wu, Alan H B ^h   Steg, Gabriel ^d   Westheim, Arne ^e   Knudsen, Catherine Wold ^e   Perez, Alberto ^h   Kazanegra, Radmila ^a   Bhalla, Vikas ^a   Herrmann, Howard C ^c   Aumont, Marie Claude ^d   McCullough, Peter A ⁱ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BICHAT HOSPITAL   (France)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

^h HARTFORD HOSPITAL   (United States)

ⁱ TRUMAN MEDICAL CENTER   (United States)

^j VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DYSPNEA; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; SENSITIVITY AND SPECIFICITY; SEX RATIO; SINGLE BLIND PROCEDURE;

EID: 3042851924     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.01.013     Document Type: Article

References (19)

1. Nagagawa O., Ogawa Y., Itoh H., et al. Rapid transcriptional activation and early m RNA turnover of BNP in cardiocyte hypertrophy evidence for BNP as an "emergency" cardiac hormone against ventricular overload. J Clin Invest. 96:1995;1280-1287
2. Maeda K., Takayoshi T., Wada A., et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 135:1998;825-832
3. Cowie M.R., Struthers A.D., Wood D.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 350:1997;1449-1453
4. Clerico A., Iervasi G., Chicca M., et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest. 21:1998;170-179
5. Omland T Aakvaag A, Bonarjee VVS, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996;93:1963-9
6. Krishnaswamy P., Lubien E., Clopton P., et al. Utility of B- Natriuretic peptide (BNP in elucidating left ventricular dysfunction (systolic and diastolic) in patients with and without symptoms of congestive heart failure at a Veterans hospital. Am J Med. 111:2001;274-279
7. Cheng V.L., Krishnaswamy P., Kazanegra R., et al. A rapid bedside test for B-Type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure. J Am Coll Cardiol. 37:2001;386-391
8. Maisel A.S., Koon J., Krishnaswamy P., et al. Utility of B-Natriuretic peptide (BNP) as a rapid, point-of-care test for screening patients undergoing echocardiography for left ventricular dysfunction. Am Heart J. 141:2001;367-374
9. Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 2002;39:131-8
10. Davis M., Espiner E., Richards G., et al. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet. 343:1994;440-444
11. Dao Q., Krishnaswamy P., Kazanegra R., et al. Utility of B-type natriuretic peptide (BNP) in the diagnosis of CHF in an urgent care setting. J Am Coll Cardiol. 37:2001;379-385
12. Morrison K.L., Harrison A., Krishnaswamy P., et al. Utility of a rapid B-natriuretic peptide (BNP) assay in differentiating CHF from lung disease in patients presenting with dyspnea. J Am Coll Cardiol. 39:2002;202-209
13. Mair J., Hammerer-Lercher A., Puscheforf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med. 39:2001;571-588
14. Wang T.J., Larson M., Levy D., et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 90:2002;254-258
15. Redfield M.M., Rodheffer R.F., Mahoney D.W., et al. Plasma brain natriuretic peptide concentration impact of age and gender. J Am Coll Cardiol. 40:2002;976-982
16. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 347:2002;161-167
17. Grenier M. Two-graph receiver operating characteristic (TG-ROC) update version supports optimization of cut-off values that minimize overall misclassification costs. J Immunol Methods. 191:1996;93-94
18. Weintraub W.S., Cole J., Tooley J.F. Cost and cost-effectiveness studies in heart failure research. Am Heart J. 143:2002;566-576
19. Hagen M.D. Test characteristics how good is that test? Primary Care. 22:1995;213-233